The Calmer Co International Limited

CCO

AU0000275216

Pharmaceuticals

Market Closed - Australian S.E. Other stock markets 01:56:20 2024-06-04 EDT			5-day change	1st Jan Change
0.006 ^AUD	0.00%		0.00%	-14.29%

06-03	The Calmer Co to Raise Up to AU$2 Million via Renounceable Rights Issue	MT
05-15	The Calmer Co International Sees Continuous Growth of eCommerce Sales; Shares Jump 33%	MT

FijiKava Ltd Appoints Network Nutrition as Exclusive Specialty Ingredient Partner in USA

October 25, 2021 at 07:05 pm

FijiKava Ltd. announced the appointment of Network Nutrition as their exclusive marketing partner in the USA for Specialty Ingredient sales. FijiKava's bulk raw ingredients will be sold via Network Nutrition as Authentic Fijian Kava? or KavatonTM into the nutraceutical and food ingredient market in the USA.

Latest news about The Calmer Co International Limited

The Calmer Co to Raise Up to AU$2 Million via Renounceable Rights Issue	06-02	MT
The Calmer Co International Sees Continuous Growth of eCommerce Sales; Shares Jump 33%	05-14	MT
The Calmer Co International Issues Loan Notes to Replace Convertible Notes	04-12	MT
The Calmer Co International's E-Commerce Sales Jump 25% in March	04-02	MT
10,000,000 Ordinary Shares of The Calmer Co International Limited are subject to a Lock-Up Agreement Ending on 13-MAR-2024.	03-12	CI
The Calmer Co International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-28	CI
The Calmer Co’s Fiji Kava Instant to Launch on Walmart.com; Shares Up 40%	02-22	MT
The Calmer Co. Completes Shipment of Initial Orders for Kava Products to Coles	02-14	MT
The Calmer Co International Logs Over 106% Boost in October-December 2023 Revenue	01-31	MT
The Calmer Co International's December 2023 E-Commerce Sales Exceed AU$250,000; Shares Jump 17%	01-22	MT
The Calmer Co. International Limited Announces Change of Company Secretary	01-17	CI
The Calmer Co International Limited Announces Sales Results for the Month Ended November 30, 2023	12-13	CI
The Calmer Co. International Raises AU$700,000 Via Convertible Bond Issue	12-04	MT
The Calmer to Launch Fiji Rugby Kava, Kava-Shots in 2024	12-01	MT
The Calmer Co. International Posts 70% Jump in Australian E-commerce Sales	11-30	MT
Calmer Co International's Kavaton Extract Used in Metagenics USA's MetaSleep	11-28	MT
The Calmer Co. International to Introduce Taki Mai Kava-Shot; Shares Jump 17%	11-20	MT
The Calmer Co International, RooLife Group Partnership Launches Flagship Store in China on Alibaba’s Tmall	23-10-23	MT
The Calmer Co International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
The Calmer Co. International Teams Up With Boutique Distribution Company	23-08-14	MT
The Calmer Co. Completes Rights Issue	23-07-31	MT
The Calmer Co. International Signs Term Sheet to Distribute Leilo-branded Beverages	23-07-24	MT
The Calmer Co. Introduces Noble Focus Online	23-07-20	MT
The Calmer Co. International Launches E-Commerce Store in US	23-06-22	MT
The Calmer Co International Limited Expands US Market Presence with New E-Commerce Store	23-06-21	CI

Chart The Calmer Co International Limited

Duration

Period

Chart The Calmer Co International Limited

More charts

Company Profile

The Calmer Co. International Limited is a health and wellness company with operations in Australia, Fiji, and the USA. The Company produces natural products to reduce anxiety, promote relaxation, improve sleep, and support sports recovery and performance. The company works with farmers to source high quality kava and hemp that is processed into active extracts for business to business (B2B) sales or into finished products across a house of brands. The Companyâs brands include Fiji Kava, Taki Mai, and Danodan Hempworks. Its Taki Mai and Fiji Kava brands are focused on expanding the distribution of kava throughout global markets to provide a natural alternative to alcohol and to small molecule sleep and antianxiety prescription medicines. Its Danodan brand offers a patented range of USDA certified organic tinctures, and soon topicals, sold throughout the USA and online for relaxation, sleep, and recovery.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Alternative Medicine

	1st Jan change	Capi.
THE CALMER CO INTERNATIONAL LIMITED	-14.29%	5.54M
DONG-E-E-JIAO CO.,LTD.	+39.90%	6.01B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-22.06%	4.11B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+10.94%	3.28B
TASLY PHARMACEUTICAL GROUP CO., LTD	-18.63%	2.83B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-9.17%	2.31B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+44.13%	1.9B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-5.16%	1.55B
ZHEJIANG JOLLY PHARMACEUTICAL CO.,LTD	+52.16%	1.51B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-16.04%	1.49B